Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms

References

• NilssonBBümmingPMeis-KindblomJMGastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era – a population-based study in western SwedenCancer2005103482182915648083
   PubMed Web of Science ®Google Scholar
• MurphyJDMaGLBaumgartnerJMIncreased risk of additional cancers among patients with gastrointestinal stromal tumors: a population-based studyCancer2015121172960296725930983
   PubMed Web of Science ®Google Scholar
• PandurenganRKDumontAGAraujoDMSurvival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumorAnn Oncol201021102107211120348145
   PubMed Web of Science ®Google Scholar
• AgaimyAWünschPHSobinLHLasotaJMiettinenMOccurrence of other malignancies in patients with gastrointestinal stromal tumorsSemin Diagn Pathol200623212012917193825
   PubMed Web of Science ®Google Scholar
• SalarARamónJMBarrancoCDouble diagnosis in cancer patients and cutaneous reaction related to gemcitabine: Case 1. Synchronous mucosa-associated lymphoid tissue lymphoma and gastrointestinal stromal tumors of the stomachJ Clin Oncol200523287221722316192606
   PubMed Web of Science ®Google Scholar
• KaffesAHughesLHollinsheadJKatelarisPSynchronous primary adenocarcinoma, mucosa-associated lymphoid tissue lymphoma and a stromal tumor in a Helicobacter pylori-infected stomachJ Gastroenterol Hepatol20021791033103612167128
   PubMed Web of Science ®Google Scholar
• ThomasALinkBKAltekruseSRomittiPASchroederMCPrimary breast lymphoma in the United States: 1975–2013J Natl Cancer Inst20171096
   Google Scholar
• SiddiquiFAMaheshwariVAlamKJainACoexistent non-Hodgkins lymphoma and ductal carcinoma breast: diagnosis on fine needle aspiration cytologyDiagn Cytopathol2011391076776921919216
   PubMed Web of Science ®Google Scholar
• HwangDGQianXHornickJLDOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocksAm J Clin Pathol2011135344845321350101
   PubMed Web of Science ®Google Scholar
• KaranikasMMachairiotisNZarogoulidisPNon-Hodgkin lymphoma and GIST: molecular pathways and clinical expressionsOnco Targets Ther2012543343823251094
   PubMed Web of Science ®Google Scholar
• CallJWalentasCDEickhoffJCScherzerNSurvival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registryBMC Cancer2012129022429770
   PubMed Web of Science ®Google Scholar
• AvivATadmorTPolliackAPrimary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic optionsAnn Oncol20132492236224423712546
   PubMed Web of Science ®Google Scholar
• HoseinPJMaraguliaJCSalzbergMPA multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab eraBr J Haematol2014165335836324467658
   PubMed Web of Science ®Google Scholar
• YoshidaSNakamuraNSasakiYPrimary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotypeMod Pathol200518339840515492762
   PubMed Web of Science ®Google Scholar
• TalwalkarSSValbuenaJRAbruzzoLVMALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breastMod Pathol200619111402140816917511
   PubMed Web of Science ®Google Scholar
• MartinelliGRyanGSeymourJFPrimary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study GroupAnn Oncol200920121993199919570964
   PubMed Web of Science ®Google Scholar
• TeckieSQiSLovieSLong-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intentInt J Radiat Oncol Biol Phys201592113013725863760
   PubMed Web of Science ®Google Scholar
• GascoyneRDAdomatSAKrajewskiSPrognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin’s lymphomaBlood19979012442519207459
   PubMed Web of Science ®Google Scholar
• MiyashitaTReedJCBcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell lineBlood19938111511578417786
   PubMed Web of Science ®Google Scholar
• VegaFMedeirosLJMarginal-zone B-cell lymphoma of extranodal mucosa-associated lymphoid tissue type: molecular genetics provides new insights into pathogenesisAdv Anat Pathol20018631332611707622
   PubMed Web of Science ®Google Scholar
• KindblomLGRemottiHEAldenborgFMeis-KindblomJMGastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of CajalAm J Pathol19981525125912699588894
   PubMed Web of Science ®Google Scholar
• CorlessCLBarnettCMHeinrichMCGastrointestinal stromal tumours: origin and molecular oncologyNat Rev Cancer2011111286587822089421
   PubMed Web of Science ®Google Scholar
• BaiCGHouXWWangFStem cell factor-mediated wild-type KIT receptor activation is critical for gastrointestinal stromal tumor cell growthWorld J Gastroenterol201218232929293722736916
   PubMed Web of Science ®Google Scholar
• LambaGAmbraleSLeeBGuptaRRafiyathSMLiuDRecent advances and novel agents for gastrointestinal stromal tumor (GIST)J Hematol Oncol201252122569033
   PubMed Web of Science ®Google Scholar
• JoensuuHWardelmannESihtoHEffect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: an exploratory analysis of a randomized clinical trialJAMA Oncol20173560260928334365
   PubMed Web of Science ®Google Scholar
• CaoCLNiuHJKangSPCongCLKangSRmiRNA-21 sensitizes gastrointestinal stromal tumors (GISTs) cells to imatinib via targeting B-cell lymphoma 2 (Bcl-2)Eur Rev Med Pharmacol Sci201620173574358127649657
   PubMed Web of Science ®Google Scholar
• GoHJangJYKimPJMicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphomaOncotarget2015617150351504925909227
   PubMedGoogle Scholar
• LiuKduJRuanLMicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2Exp Ther Med20171454489449629067124
   PubMed Web of Science ®Google Scholar
• BaiHWeiJDengCYangXWangCXuRMicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimenInt J Hematol201397222323123275230
   PubMed Web of Science ®Google Scholar